![]() |
|
|
-Sheet in Divalent Cation Modulation of
7 Nicotinic Receptors
Departments of Pharmacology (J.T.M., J.F., A.D.S., R.L.R.) and Cell & Molecular Physiology (R.L.R.), University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
-7 Nicotinic acetylcholine receptors (AChRs) exhibit a positive modulation by divalent cations similar to that observed in other AChRs. In the chick
7 AChR, this modulation involves a conserved glutamate in loop 9 (Glu172) that undergoes agonist-dependent movements during activation. From these observations, we hypothesized that movements of the nearby
-sheet formed by the
7,
9, and
10 strands may be involved in agonist activation and/or divalent modulation. To test this hypothesis, we examined functional properties of cysteine mutations of the
7 and
10 strands, alone or in pairs. We postulated that reduced flexibility or mobility of the
7/
9/
10-sheet as a result of introduction of a disulfide bond between the
strands would alter activation by agonists. Using a nondesensitizing
7 mutant background (L247T), we identified one mutant pair, K144C + T198C, that exhibited a unique characteristic: it was fully activated by divalent cations (Ca2+, Ba2+, or Sr2+) in the absence of acetylcholine (ACh). Divalent-evoked currents were blocked by the
7 antagonist methyllycaconitine and were abolished when Glu172 was mutated to glutamine. When the K144C + T198C pair was expressed in wild-type
7 receptors, activation required both ACh and divalent cations. We conclude that the introduction of a disulfide bond into
7/
9/
10 lowers the energetic barrier between open and closed conformations, probably by reducing the torsional flexibility of the
-sheet. In this setting, divalent cations, acting at the conserved glutamate in loop 9, act as full agonists or requisite coagonists.
Address correspondence to: Dr. James T. McLaughlin, Department of Pharmacology, CB# 7365, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365. E-mail: jmclaughlin{at}unc.edu
Related articles in MolPharm:
This article has been cited by other articles:
![]() |
E. A. Gay and J. L. Yakel Gating of nicotinic ACh receptors; new insights into structural transitions triggered by agonist binding that induce channel opening J. Physiol., November 1, 2007; 584(3): 727 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. McLaughlin, J. Fu, and R. L. Rosenberg Agonist-Driven Conformational Changes in the Inner beta-Sheet of {alpha}7 Nicotinic Receptors Mol. Pharmacol., May 1, 2007; 71(5): 1312 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsuneki, S. Kobayashi, K. Takagi, S. Kagawa, M. Tsunoda, M. Murata, T. Matsuoka, T. Wada, M. Kurachi, I. Kimura, et al. Novel G423S Mutation of Human {alpha}7 Nicotinic Receptor Promotes Agonist-Induced Desensitization by a Protein Kinase C-Dependent Mechanism Mol. Pharmacol., March 1, 2007; 71(3): 777 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lindstrom Potentiation of Acetylcholine Receptors by Divalent Cations Mol. Pharmacol., July 1, 2006; 70(1): 5 - 7. [Abstract] [Full Text] [PDF] |
||||